Ayr Wellness Inc. (AYRWF) EBITDA (2019 - 2025)

Ayr Wellness (AYRWF) has reported EBITDA for 7 consecutive years, with -$28.2 million the latest figure, recorded in Q1 2025.

• On a quarterly basis, EBITDA fell 197.03% year-over-year to -$28.2 million in Q1 2025; TTM through Mar 2025 was $42.7 million, a 44.92% decrease from a year earlier, with the FY2024 full-year figure at $100.0 million, down 12.28% from the prior year.
• EBITDA was -$28.2 million for Q1 2025 at Ayr Wellness, down from $19.1 million in the prior quarter.
• Over five years, EBITDA peaked at $29.4 million in Q2 2023 and troughed at -$28.2 million in Q1 2025.
• A 5-year average of $12.7 million and a median of $25.7 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA soared 626.69% in 2021 and tumbled 197.03% in 2025, its largest moves.
• Over 5 years, EBITDA stood at $26.1 million in 2021, then fell by 0.47% to $26.0 million in 2022, then slumped by 136.29% to -$9.4 million in 2023, then surged by 302.31% to $19.1 million in 2024, then slumped by 247.83% to -$28.2 million in 2025.
• The last three EBITDA figures came in at -$28.2 million (Q1 2025), $19.1 million (Q4 2024), and $26.1 million (Q3 2024), per Business Quant data.